Zimmer Biomet

Zimmer Biomet designs, develops, manufactures and markets orthopaedic reconstructive, including knee, hip, shoulder, elbow, foot and ankle artificial joints, spinal and trauma devices, dental implants and related surgical products. The Company operates through four segments: Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.

Company Growth (employees)
Type
Public
HQ
Warsaw, US
Founded
1927
Size (employees)
18,500 (est)
Zimmer Biomet was founded in 1927 and is headquartered in Warsaw, US

Zimmer Biomet Office Locations

Zimmer Biomet has an office in Warsaw
Warsaw, US (HQ)
345 E Main St

Zimmer Biomet Data and Metrics

Zimmer Biomet Financial Metrics

Zimmer Biomet's revenue was reported to be $7.7 b in FY, 2016 which is a 28% increase from the previous period.
USD

Revenue (FY, 2016)

7.7 b

Revenue growth (FY, 2015 - FY, 2016), %

28%

Gross profit (FY, 2016)

5.3 b

Gross profit margin (FY, 2016), %

69%

Net income (FY, 2016)

304.6 m

EBIT (FY, 2016)

825.9 m

Market capitalization (19-Sep-2017)

23.4 b

Closing share price (19-Sep-2017)

116.3

Cash (31-Dec-2016)

634.1 m

EV

34 b
Zimmer Biomet's current market capitalization is $23.4 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

4.6 b4.7 b6 b7.7 b

Revenue growth, %

1%28%28%

Cost of goods sold

1.3 b1.2 b1.8 b2.4 b

Gross profit

3.3 b3.4 b4.2 b5.3 b
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

1.1 b1.1 b1.5 b634.1 m

Inventories

1.1 b1.2 b2.3 b2 b

Current Assets

4.2 b4.3 b5.9 b4.7 b

PP&E

1.2 b1.3 b2.1 b2 b
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

759.2 m719 m146.2 m304.6 m

Inventories

(128.4 m)(154.1 m)(205.4 m)76.4 m

Cash From Operating Activities

963.1 m1.1 b816.7 m1.6 b

Cash From Investing Activities

(282.5 m)(469.4 m)(7.6 b)(1.7 b)
USDY, 2016

EV/EBIT

41.1 x

EV/CFO

20.8 x

Revenue/Employee

426.9 k

Debt/Equity

1.2 x

Debt/Assets

0.4 x

Financial Leverage

2.8 x
Show all financial metrics

Zimmer Biomet Market Value History

Traffic Overview of Zimmer Biomet

Zimmer Biomet Online and Social Media Presence

Zimmer Biomet News and Updates

Trump’s Pick for Health Secretary Under Scrutiny for Investments

Democrats have called for investigations into whether Representative Tom Price violated insider trading laws or conflict of interest rules.

Senators call for investigation of Tom Price's healthcare investments

Democrats raise concern over health secretary nominee, who bought and sold health-related stocks while he was an influential voice on healthcare policyDonald Trump’s choice for health secretary, Tom Price, faces his first congressional grilling on Wednesday, hours after leading Democrats called for …

Senate panel to hear from Trump's Health secretary pick amid rising ethics questions

Amid rising criticism of his record and questions about his extensive trading in healthcare stocks, Rep. Tom Price is set to appear before the Senate Health Committee on Wednesday in his bid to become President-elect Donald Trump’s Health and Human Services secretary. Price, an orthopedic surgeo…

Editorial: Tom Price’s Dubious Trades in Health Care Stocks

The health secretary nominee needs to explain his investments as well as address confusion about the Trump team’s plans to replace Obamacare.

Trump Health Secretary Pick’s Longtime Foes: Big Government and Insurance Companies

Over a long political career, Tom Price, a doctor, never swerved from his policy mission to protect his former profession from what he views as heavy-handed government intrusion.

US Stock Indexes Edge Mostly Lower in Early Trading

Real estate companies led U.S. stocks mostly lower in early trading Tuesday. Energy and consumer-goods stocks also fell as crude oil prices headed lower. Industrials companies notched the biggest gain.
Show more

Zimmer Biomet Company Life and Culture

You may also be interested in